Quality of Life in Daxas-treated Patients Older Than 18 Years With Severe COPD
NCT01285180
·
clinicaltrials.gov ↗
COMPLETED
Status
5472
Enrollment
INDUSTRY
Sponsor class
Conditions
Severe COPD
Interventions
DRUG:
Daxas
Sponsor
AstraZeneca